Amgen (AMGN) Net Income towards Common Stockholders (2009 - 2026)
Amgen (AMGN) posted Net Income towards Common Stockholders of $2.38 billion for Q2 2026, up 65.9% from $1.43 billion a year earlier and up 30.6% from the prior quarter.
Powered by 
Analysis
Amgen (AMGN) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Income towards Common Stockholders at Amgen was $8.74 billion, up 32.1% year-over-year; for FY2025, it was $7.71 billion, up 88.5% from FY2024.
- Annual Net Income towards Common Stockholders shows a five-year compound annual growth rate of 1.2% (FY2020 to FY2025).
- In prior years, Amgen's Net Income towards Common Stockholders was $4.09 billion in FY2024 (-39.1%), $6.72 billion in FY2023 (+2.5%), $6.55 billion in FY2022 (+11.2%) and $5.89 billion in FY2021 (-18.9%).
- Quarterly Net Income towards Common Stockholders has run from a low of -$113 million in Q1 2024 to a high of $3.22 billion in Q3 2025 over five years.
- On a year-over-year basis, Net Income towards Common Stockholders has increased in each of the last five quarters, with growth averaging 47.8% over the last seven quarters.
- The strongest year-over-year quarter for Net Income towards Common Stockholders in the past five years was Q2 2022, with growth of 183.8%; the weakest was Q4 2023, with a decline of 52.5%.
- According to Business Quant data, Net Income towards Common Stockholders for the three prior quarters was $1.82 billion (Q1 2026), $1.33 billion (Q4 2025) and $3.22 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,039.78 Bn | 1,008.37 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 598.09 Bn | 516.62 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 485.25 Bn | 458.37 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 350.07 Bn | 304.45 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 276.00 Bn | 239.99 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 241.60 Bn | 215.28 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 222.93 Bn | 178.33 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 183.81 Bn | 158.01 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 161.60 Bn | 108.24 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Vertex Pharmaceuticals | 123.05 Bn | 95.06 Bn | 2.84 Bn | 1.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.38 Bn |
| Mar 31, 2026 | 1.82 Bn |
| Dec 31, 2025 | 1.33 Bn |
| Sep 30, 2025 | 3.22 Bn |
| Jun 30, 2025 | 1.43 Bn |
| Mar 31, 2025 | 1.73 Bn |
| Dec 31, 2024 | 627.00 Mn |
| Sep 30, 2024 | 2.83 Bn |
| Jun 30, 2024 | 746.00 Mn |
| Mar 31, 2024 | -113.00 Mn |
| Dec 31, 2023 | 767.00 Mn |
| Sep 30, 2023 | 1.73 Bn |
| Jun 30, 2023 | 1.38 Bn |
| Mar 31, 2023 | 2.84 Bn |
| Dec 31, 2022 | 1.62 Bn |
| Sep 30, 2022 | 2.14 Bn |
| Jun 30, 2022 | 1.32 Bn |
| Mar 31, 2022 | 1.48 Bn |
| Dec 31, 2021 | 1.90 Bn |
| Sep 30, 2021 | 1.88 Bn |
API Access
Amgen Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=AMGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "AMGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=AMGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();